Gideon Capital Advisors’s Bio-Techne TECH Stock Holding History

Gideon Capital Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,148	Closed	-$560K	–	490
2018 Q2	$560K	Buy	+15,148	New	+$578K	0.28%	114

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Gideon Capital Advisors's TECH Position: Q3 2018 in Review

Gideon Capital Advisors sold out of Bio-Techne (TECH) in Q3 2018, closing a stake of 15,148 shares — an estimated $560K sold.

Gideon Capital Advisors first reported a position in TECH in Q2 2018 and held it in 1 quarter. The position peaked at $560K in Q2 2018. 344 funds tracked by Wall St. Rank hold TECH as of Q3 2018.

Gideon Capital Advisors reported no remaining Bio-Techne position as of Q3 2018 after selling out during the quarter.
Gideon Capital Advisors sold 15,148 Bio-Techne shares in Q3 2018, an estimated $560K.
Gideon Capital Advisors first reported a position in Bio-Techne in Q2 2018 and held it in 1 quarter.
Gideon Capital Advisors's Bio-Techne position peaked at $560K in Q2 2018.
344 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2018.

Based on Gideon Capital Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.